{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:02Z","timestamp":1790713142334,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11046-015-9969-z","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T05:28:55Z","timestamp":1448515735000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses"],"prefix":"10.1007","volume":"181","author":[{"given":"Yasemin","family":"\u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva G\u00fcl","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egemen","family":"G\u00f6kbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macit","family":"Ilkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"issue":"3","key":"9969_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/02713683.2010.533810","volume":"36","author":"A Kalkanci","year":"2011","unstructured":"Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011;36(3):179\u201389.","journal-title":"Curr Eye Res"},{"issue":"6","key":"9969_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.125.6.789","volume":"125","author":"P Lalitha","year":"2007","unstructured":"Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007;125(6):789\u201393.","journal-title":"Arch Ophthalmol"},{"key":"9969_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-1-4160-0016-7.50018-7","volume-title":"Albert and Jakobiec\u2019s principles and practice of opthalmology","author":"WA Schell","year":"2008","unstructured":"Schell WA, Foulks GN, Perfect JR. Fungal infections of the eye. In: Albert D, Miller J, Azar D, Blodi B, editors. Albert and Jakobiec\u2019s principles and practice of opthalmology. Philadelphia: Saunders; 2008. p. 159\u201368."},{"issue":"4","key":"9969_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CMR.16.4.730-797.2003","volume":"16","author":"PA Thomas","year":"2003","unstructured":"Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16(4):730\u201397.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"9969_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00055735-200408000-00008","volume":"15","author":"M Srinivasan","year":"2004","unstructured":"Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15(4):321\u20137.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"9969_CR6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1442-9071.2010.02473.x","volume":"39","author":"R Arora","year":"2011","unstructured":"Arora R, Gupta D, Goyal J, Kaur R. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Clin Exp Ophthalmol. 2011;39(5):434\u201340.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"9969_CR7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICO.0b013e318254a41b","volume":"32","author":"T Ramakrishnan","year":"2013","unstructured":"Ramakrishnan T, Constantinou M, Jhanji V, Vajpayee RB. Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis. Cornea. 2013;32(4):445\u20139.","journal-title":"Cornea"},{"issue":"10","key":"9969_CR8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/bjo.2010.191734","volume":"95","author":"Y Matsumoto","year":"2011","unstructured":"Matsumoto Y, Murat D, Kojima T, Shimazaki J, Tsubota K. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. The British journal of ophthalmology. 2011;95(10):1406\u20139.","journal-title":"The British journal of ophthalmology"},{"issue":"3\u20134","key":"9969_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11046-013-9625-4","volume":"175","author":"S Saha","year":"2013","unstructured":"Saha S, Sengupta J, Banerjee D, Khetan A, Mandal SM. Schizophyllum commune: a new organism in eye infection. Mycopathologia. 2013;175(3\u20134):357\u201360.","journal-title":"Mycopathologia"},{"issue":"1\u20132","key":"9969_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11046-013-9721-5","volume":"177","author":"V Buchta","year":"2014","unstructured":"Buchta V, Feuermannova A, Vasa M, et al. Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery. Mycopathologia. 2014;177(1\u20132):115\u201321.","journal-title":"Mycopathologia"},{"issue":"4","key":"9969_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/myc.12306","volume":"58","author":"L Kredics","year":"2015","unstructured":"Kredics L, Narendran V, Shobana CS, Vagvolgyi C, Manikandan P. Indo-Hungarian Fungal Keratitis Working G. Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses. 2015;58(4):243\u201360.","journal-title":"Mycoses"},{"issue":"1","key":"9969_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1439-0507.2012.02194.x","volume":"56","author":"P Manikandan","year":"2013","unstructured":"Manikandan P, Varga J, Kocsube S, et al. Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents. Mycoses. 2013;56(1):26\u201333.","journal-title":"Mycoses"},{"key":"9969_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mmcr.2013.04.002","volume":"2","author":"N Baranyi","year":"2013","unstructured":"Baranyi N, Kocsube S, Szekeres A, et al. Keratitis caused by Aspergillus pseudotamarii. Med Mycol Case Rep. 2013;2:91\u20134.","journal-title":"Med Mycol Case Rep"},{"issue":"10","key":"9969_CR14","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/JCM.00920-07","volume":"45","author":"L Kredics","year":"2007","unstructured":"Kredics L, Varga J, Kocsube S, et al. Case of keratitis caused by Aspergillus tamarii. J Clin Microbiol. 2007;45(10):3464\u20137.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"9969_CR15","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JCM.01051-09","volume":"47","author":"P Manikandan","year":"2009","unstructured":"Manikandan P, Varga J, Kocsube S, et al. Mycotic keratitis due to Aspergillus nomius. J Clin Microbiol. 2009;47(10):3382\u20135.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"9969_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/ICO.0b013e3181967098","volume":"28","author":"L Kredics","year":"2009","unstructured":"Kredics L, Varga J, Kocsube S, et al. Infectious keratitis caused by Aspergillus tubingensis. Cornea. 2009;28(8):951\u20134.","journal-title":"Cornea"},{"key":"9969_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1752-1947-4-68","volume":"4","author":"P Manikandan","year":"2010","unstructured":"Manikandan P, Varga J, Kocsube S, et al. Keratitis caused by the recently described new species Aspergillus brasiliensis: two case reports. J Med Case Rep. 2010;4:68.","journal-title":"J Med Case Rep"},{"key":"9969_CR18","unstructured":"CLSI. Method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: approved standard M38-A2 (Eds). Wayne: Clinical and Laboratory Standards Institute; 2002"},{"issue":"6","key":"9969_CR19","first-page":"594","volume":"49","author":"N Kiraz","year":"2011","unstructured":"Kiraz N, Oz Y, Dag I. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays. Med Mycol. 2011;49(6):594\u2013601.","journal-title":"Med Mycol"},{"issue":"2","key":"9969_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003088-200544020-00005","volume":"44","author":"JW Mouton","year":"2005","unstructured":"Mouton JW, Vinks AA. Pharmacokinetic\/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration. Clin Pharmacokinet. 2005;44(2):201\u201310.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"9969_CR21","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/JCM.39.9.3402-3408.2001","volume":"39","author":"J Meletiadis","year":"2001","unstructured":"Meletiadis J, Mouton JW, Meis JF, et al. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol. 2001;39(9):3402\u20138.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"9969_CR22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/dku431","volume":"70","author":"BE Ferro","year":"2015","unstructured":"Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW. Time-kill kinetics of antibiotics active against rapidly growing mycobacteria. J Antimicrob Chemother. 2015;70(3):811\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"9969_CR23","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","volume":"49","author":"JW Linden Van Der","year":"2011","unstructured":"Van Der Linden JW, Warris A, Verweij PE. Aspergillus species intrinsically resistant to antifungal agents. Med Mycol. 2011;49(Suppl 1):S82\u20139.","journal-title":"Med Mycol"},{"issue":"6","key":"9969_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","volume":"12","author":"PE Verweij","year":"2009","unstructured":"Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat. 2009;12(6):141\u20137.","journal-title":"Drug Resist Updat"},{"issue":"14","key":"9969_CR25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","volume":"356","author":"PE Verweij","year":"2007","unstructured":"Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med. 2007;356(14):1481\u20133.","journal-title":"N Engl J Med"},{"issue":"10","key":"9969_CR26","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.47.10.3085-3088.2003","volume":"47","author":"A Gomez-Lopez","year":"2003","unstructured":"Gomez-Lopez A, Garcia-Effron G, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 2003;47(10):3085\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"9969_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","volume":"57","author":"JW Linden van der","year":"2013","unstructured":"van der Linden JW, Camps SM, Kampinga GA, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis. 2013;57(4):513\u201320.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9969_CR28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/EC.00425-07","volume":"7","author":"J Varga","year":"2008","unstructured":"Varga J, Houbraken J, Der Van, Lee HA, Verweij PE, Samson RA. Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot Cell. 2008;7(4):630\u20138.","journal-title":"Eukaryot Cell"},{"issue":"2","key":"9969_CR29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.00335-08","volume":"53","author":"C Lass-Florl","year":"2009","unstructured":"Lass-Florl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL. In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother. 2009;53(2):794\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"9969_CR30","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","volume":"55","author":"SJ Howard","year":"2011","unstructured":"Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011;55(10):4802\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"9969_CR31","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1128\/AAC.00585-09","volume":"53","author":"L Alcazar-Fuoli","year":"2009","unstructured":"Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009;53(10):4514\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"9969_CR32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.2007.136515","volume":"92","author":"SM Hariprasad","year":"2008","unstructured":"Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92(7):871\u20138.","journal-title":"Br J Ophthalmol"},{"key":"9969_CR33","first-page":"391","volume":"4","author":"D Al-Badriyeh","year":"2010","unstructured":"Al-Badriyeh D, Neoh CF, Stewart K, Kong DC. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol. 2010;4:391\u2013405.","journal-title":"Clin Ophthalmol"},{"key":"9969_CR34","author":"A Altun","year":"2014","unstructured":"Altun A, Kurna SA, Sengor T et al. Effectiveness of posaconazole in recalcitrant fungal keratitis resistant to conventional antifungal drugs. Case Rep Ophthalmol Med. 2014. doi: 10.1155\/2014\/701653 .","journal-title":"Case Rep Ophthalmol Med"},{"issue":"10","key":"9969_CR35","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","volume":"47","author":"JW Baddley","year":"2009","unstructured":"Baddley JW, Marr KA, Andes DR, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47(10):3271\u20135.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"9969_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","volume":"48","author":"A Alastruey-Izquierdo","year":"2010","unstructured":"Alastruey-Izquierdo A, Cuesta I, Houbraken J, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. Med Mycol. 2010;48(1):97\u2013102.","journal-title":"Med Mycol"},{"issue":"2","key":"9969_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/46.2.229","volume":"46","author":"EK Manavathu","year":"2000","unstructured":"Manavathu EK, Cutright JL, Loebenberg D, Chandrasekar PH. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). J Antimicrob Chemother. 2000;46(2):229\u201334.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"9969_CR38","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jac\/dkn069","volume":"61","author":"RE Lewis","year":"2008","unstructured":"Lewis RE, Albert ND, Kontoyiannis DP. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J Antimicrob Chemother. 2008;61(5):1140\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"9969_CR39","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol. 2013;51(8):2571\u201381.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"9969_CR40","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JCM.00863-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. J Clin Microbiol. 2013;51(8):2608\u201316.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"9969_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2010.08.013","volume":"69","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn Microbiol Infect Dis. 2011;69(1):45\u201350.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"9969_CR42","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","volume":"54","author":"MR Shivaprakash","year":"2011","unstructured":"Shivaprakash MR, Geertsen E, Chakrabarti A, Mouton JW, Meis JF. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs. Mycoses. 2011;54(5):e583\u20139.","journal-title":"Mycoses"},{"issue":"8","key":"9969_CR43","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.00428-11","volume":"55","author":"SR Lockhart","year":"2011","unstructured":"Lockhart SR, Zimbeck AJ, Baddley JW, et al. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother. 2011;55(8):3944\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9969_CR44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2013.10.004","volume":"157","author":"P Lalitha","year":"2014","unstructured":"Lalitha P, Sun CQ, Prajna NV, et al. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol. 2014;157(2):318\u201326.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"9969_CR45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12126","volume":"19","author":"PA Thomas","year":"2013","unstructured":"Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210\u201320.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"9969_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0896-1549(05)70147-4","volume":"12","author":"TP O\u2019Brien","year":"1999","unstructured":"O\u2019Brien TP. Therapy of ocular fungal infections. Ophthalmol Clin North Am. 1999;12(1):33\u201350.","journal-title":"Ophthalmol Clin North Am"},{"issue":"2","key":"9969_CR47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S0034-72802013000200014","volume":"72","author":"GG M\u00fcller","year":"2013","unstructured":"M\u00fcller GG, Kara-Jos\u00e9 N, de Castro RS. Antifungals in eye infections: drugs and routes of administration. Rev Bras Oftalmol. 2013;72(2):132\u201341.","journal-title":"Rev Bras Oftalmol."},{"issue":"5","key":"9969_CR48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/jop.2008.0031","volume":"24","author":"IP Kaur","year":"2008","unstructured":"Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther. 2008;24(5):481\u201393.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"9969_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/33.2.203","volume":"33","author":"SH Khoo","year":"1994","unstructured":"Khoo SH, Bond J, Denning DW. Administering amphotericin B\u2014a practical approach. J Antimicrob Chemother. 1994;33(2):203\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"9969_CR50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.31.1.6","volume":"31","author":"DV Savani","year":"1987","unstructured":"Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987;31(1):6\u201310.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-015-9969-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-015-9969-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-015-9969-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:06:55Z","timestamp":1553612815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-015-9969-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":50,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9969"],"URL":"https:\/\/doi.org\/10.1007\/s11046-015-9969-z","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]}}}